Gores Group realises 10x return on Therakos
The firm has made a record gain through the $1.3 billion sale of the immunotherapy company to Mallinckrodt.
The firm has made a record gain through the $1.3 billion sale of the immunotherapy company to Mallinckrodt.
Copyright PEI Media
Not for publication, email or dissemination